Department of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Sugitani, Toyama 930-0194, Japan.
Department of Pharmaceutical Therapy and Neuropharmacology, Graduate School of Medical and Pharmaceutical Sciences, University of Toyama, Sugitani, Toyama 930-0194, Japan.
Int J Mol Sci. 2022 Oct 31;23(21):13259. doi: 10.3390/ijms232113259.
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that requires further pathological elucidation to establish effective treatment strategies. We previously showed that amyloid β (Aβ) toxic conformer with a turn at positions 22-23 is essential for forming highly toxic oligomers. In the present study, we evaluated phenotypic changes with aging in AD model (NL-P-F) mice with Swedish mutation (NL), Iberian mutation (F), and mutation (P) overproducing E22P-Aβ, a mimic of toxic conformer utilizing the knock-in technique. Furthermore, the role of the toxic conformer in AD pathology was investigated. NL-P-F mice produced soluble toxic conformers from an early age. They showed impaired synaptic plasticity, glial cell activation, and cognitive decline, followed by the accumulation of Aβ plaques and tau hyperphosphorylation. In addition, the protein expression of hypoxia-inducible factor (HIF)-1α was increased, and gene expression of HIF-3α was decreased in NL-P-F mice. HIF dysregulation due to the production of soluble toxic conformers may be involved in AD pathology in NL-P-F mice. This study could reveal the role of a highly toxic Aβ on AD pathogenesis, thereby contributing to the development of a novel therapeutic strategy targeting the toxic conformer.
阿尔茨海默病(AD)是一种进行性神经退行性疾病,需要进一步的病理阐明,以建立有效的治疗策略。我们之前曾表明,具有 22-23 位转角的淀粉样蛋白 β(Aβ)毒性构象对于形成高度毒性寡聚体至关重要。在本研究中,我们利用基因敲入技术评估了具有瑞典突变(NL)、伊比利亚突变(F)和突变(P)的 AD 模型(NL-P-F)小鼠随年龄的表型变化,这些突变导致 E22P-Aβ过度产生,这是一种毒性构象的模拟物。此外,还研究了毒性构象在 AD 病理学中的作用。NL-P-F 小鼠从早期就产生可溶性毒性构象。它们表现出突触可塑性受损、神经胶质细胞激活和认知能力下降,随后出现 Aβ 斑块积累和 tau 过度磷酸化。此外,NL-P-F 小鼠中缺氧诱导因子(HIF)-1α的蛋白表达增加,HIF-3α的基因表达减少。由于可溶性毒性构象的产生导致 HIF 失调可能与 NL-P-F 小鼠中的 AD 病理学有关。这项研究可以揭示高度毒性 Aβ 在 AD 发病机制中的作用,从而为针对毒性构象的新型治疗策略的开发做出贡献。